S&P Healthcare Services SPDR (XHS)

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

Elevance Health is scheduled to release its Q4 results next month, and analysts project a double-digit drop in profit.

Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

After a year of clear underperformance, analysts are hitting pause and taking a more skeptical view of Molina Healthcare’s outlook.

Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Although Cigna Group has lagged the broader market, analysts remain bullish about its prospects.

DaVita has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Cardinal Health has experienced robust growth in earnings and topline recently. Observing the momentum, analysts remain strongly bullish on the stock’s prospects.

Centene has significantly underperformed the broader market and the healthcare services space over the past year, and analysts remain cautious about the stock’s prospects.

Molina Healthcare is expected to release its fiscal third-quarter earnings report this month, and analysts project a double-digit bottom-line decline.